The cytology of HIV-induced immunosuppression. Changing pattern of disease in the era of highly active antiretroviral therapy

Cytopathology

Volumn 12, Issue 5, 2001, Pages 281-296

  Kocjan, G ^a   Miller, R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS; AIDS cytology; AIDS opportunistic infections; CSF cytology; HIV cytology; HIV diagnosis; HIV FNAC; HIV infection; HIV lymphoma; HIV pathology; Kaposi's cytology; Laboratory safety; Mycobacterial infection cytology; Needlestick injury

Indexed keywords

RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASIA; ASPIRATION CYTOLOGY; AUSTRALIA; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLOGY; CYTOPATHOLOGY; DISEASE ASSOCIATION; DRUG TOLERANCE; EUROPE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPOSI SARCOMA; MORTALITY; MYCOBACTERIUM; NONHODGKIN LYMPHOMA; NORTH AMERICA; OCCUPATIONAL HAZARD; OPPORTUNISTIC INFECTION; PAROTID GLAND DISEASE; PATHOGENESIS; PLEURA EFFUSION; PNEUMOCYSTIS CARINII; POPULATION RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SKIN LYMPHOMA; TUMOR GROWTH; TUMOR LOCALIZATION; UTERINE CERVIX CARCINOMA; VIRUS LOAD;

EID: 0035788629     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2001.00331.x     Document Type: Review

References (89)

1. Miller RF. Clinical presentation and significance of emerging opportunistic infections. J Eukaryot Microbiol 2000; 47(1): 21-3.
2. Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. Aids 1998; 12 (Suppl. A): S157-63.
3. Rodriguez-Rosado R, Soriano V, Dona C, Gonzalez-Lahoz J. Opportunistic infections shortly after beginning highly active antiretroviral therapy. Antivir Ther 1998; 3: 229-31.
4. Cavert W. Preventing and treating major opportunistic infections in AIDS. What's new and what's still true. Postgrad Med 1997; 102: 125-6, 129-35, 139-40.
5. Petruckevitch A, Del Amo J, Phillips AN et al. Disease progression and survival following specific AIDS-defining conditions: A retrospective cohort study of 2048 HIV-infected persons in London. Aids 1998; 12: 1007-13.
6. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124: 633-42.
7. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination anti-retroviral therapy. Aids 1999; 13: 1933-42.
8. Selik RM, Rabkin CS. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 1998; 90: 1300-2.
9. Thomas CF Jr, Limper AH. Pneumocystis pneumonia: Clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome. Semin Respir Infect 1998; 13: 289-95.
10. Bottaro E. Pneumocystis carinii pneumonia in AIDS. New concepts for an old problem. Medicina (B Aires) 1999; 59: 187-94.
11. Miller RF. Prophylaxis of Pneumocystis carinii pneumonia: Too much of a good thing? Thorax 2000; 55 (Suppl. 1): S15-22.
12. Djamin RS, Drent M, Schreurs AJ, Groen EA, Wagenaar SS. Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients. Bronchoalveolar lavage vs. bronchial brushing. Acta Cytol 1998; 42: 933-8.
13. Schumann GB, Swensen JJ. Comparison of Papanicolaou's stain with the Gomori methenamine silver (GMS) stain for the cytodiagnosis of Pneumocystis carinii in bronchoalveolar lavage (BAL) fluid. Am J Clin Pathol 1991; 95: 583-6.
14. Griffiths MH, Kocjan G, Miller RF, Godfrey-Faussett P. Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage [see comments]. Thorax 1989; 44: 554-8.
15. Wakefield AE, Miller RF, Guiver LA, Hopkin JM. Granulomatous Pneumocystis carinii pneumonia: DNA amplification studies on bronchoscopic alveolar lavage samples [see comments]. J Clin Pathol 1994; 47: 664-6.
16. Tsolaki AG, Miller RF, Wakefield AE. Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia. J Med Microbiol 1999; 48: 897-905.
17. Ribes JA, Limper AH, Espy MJ, Smith TF. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: Analysis of sensitivity and specificity. J Clin Microbiol 1997; 35: 830-5.
18. Torres J, Goldman M, Wheat LJ et al. Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: A blinded comparison to standard methods. Clin Infect Dis January, 2000; 30: 141-5.
19. Sing A, Trebesius K, Roggenkamp A et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 2000; 38: 1461-7.
20. Khan MA, Farrag N, Butcher P. Diagnosis of Pneumocystis carinii pneumonia: Immunofluorescence staining, simple PCR or nPCR. J Infect 1999; 39: 77-80.
21. Wakefield AE, Pixley FJ, Banerji S et al. Detection of Pneumocystis carinii with DNA amplification [see comments]. Lancet 1990; 336: 451-3.
22. Wakefield AEPF, Banjeri S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 1990; 43: 69-76.
23. Churchill DHM, Miller R, Williams I, Nelson M, Miller. HIV associated culture-proven tuberculosis has increased in North Central London from 1990 to 1996. Sex Trans Infect 2000; 76: 43-5.
24. Relkin F, Aranda CP, Garay SM, Smith R, Berkowitz KA, Rom WN. Pleural tuberculosis and HIV infection [see comments]. Chest 1994; 105: 1338-41.
25. Finch D, Beaty CD. The utility of a single sputum specimen in the diagnosis of tuberculosis. Comparison between HIV-infected and non-HIV-infected patients [see comments]. Chest 1997; 111: 1174-9.
26. Ellison E, Lapuerta P, Martin SE. Fine needle aspiration diagnosis of mycobacterial lymphadenitis. Sensitivity and predictive value in the United States. Acta Cytol 1999; 43: 153-7.
27. Baek CH, Kim SI, Ko YH, Chu KC. Polymerase chain reaction detection of Mycobacterium tuberculosis from fine-needle aspirate for the diagnosis of cervical tuberculous lymphadenitis. Laryngoscope 2000; 110: 30-4.
28. Manitchotpisit B, Kunachak S, Kulapraditharom B, Sura T. Combined use of fine needle aspiration cytology and polymerase chain reaction in the diagnosis of cervical tuberculous lymphadenitis. J Med Assoc Thai 1999; 82: 363-8.
29. Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Cytomegalovirus as a primary pulmonary pathogen in AIDS [see comments]. Chest 1997; 111: 128-34.
30. Sheehan MM, Coker R, Coleman DV. Detection of cytomegalovirus (CMV) in HIV+ patients: Comparison of cytomorphology, immunocytochemistry and in situ hybridization. Cytopathol 1998; 9: 29-37.
31. Solans EP, Yong S, Husain AN, Eichorst M, Gattuso P. Bronchioloalveolar lavage in the diagnosis of CMV pneumonitis in lung transplant recipients: An immunocytochemical study. Diagn Cytopathol 1997; 16: 350-2.
32. Uberti-Foppa C, Lillo F, Terreni MR et al. Cytomegalovirus pneumonia in AIDS patients: Value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998; 113: 919-23.
33. Heurlin N, Markling L, Barkholt L, Lonnqvist B, Andersson J, Ringden O. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia. Clin Transplant 1994; 8: 466-73.
34. Miller RF, Shaw PJ, Williams IG. Immune reconstitution CMV pneumonitis [letter]. Sex Trans Infect 2000; 76: 60.
35. Whitely WTA, Peters B, Kocjan G, Miller R. Pyrexia of undetermined origin in the era of HAART. Sex Trans Infect 2000; 76: in press.
36. Fischler DF, Hall GS, Gordon S, Stoler MH, Nunez C. Aspergillus in cytology specimens: A review of 45 specimens from 36 patients. Diagn Cytopathol 1997; 16: 26-30.
37. Chetty R. HIV-associated lymphoepithelial cysts and lesions: Morphological and immuno-histochemical study of the lymphoid cells. Histopathol 1998; 33: 222-9.
38. Fortuno-Mar A, Mayayo E, Castillo A, Guiral H. [A lymphoepithelial cyst of the parotid gland in an advanced stage of HIV infection. A rare association]. An Otorrinolaringol Ibero Am 1999; 26: 469-75.
39. Chhieng DC, Argosino R, McKenna BJ, Cangiarella JF, Cohen JM. Utility of fine-needle aspiration in the diagnosis of salivary gland lesions in patients infected with human immunodeficiency virus. Diagn Cytopathol 1999; 21: 260-4.
40. Mitteldorf CA, Misiara AC, de Carvalho IE. Multicystic autoimmune thyroiditis-like disease associated with HIV infection. A case report. Acta Cytol 1999; 43: 862-6.
41. Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 1998; 23: 1-6.
42. Tirelli U, Errante D, Carbone A, Gloghini A, Vaccher E. Malignant lymphomas in patients with HIV infection. Leuk Lymphoma 1996; 22: 245-57.
43. Wool GM. AIDS-related malignancies. Oncologist 1998; 3: 279-83.
44. Cannon M, Cesarman E. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin Oncol 2000; 27: 409-19.
45. Cooksley CD, Hwang LY, Waller DK, Ford CE. HIV-related malignancies: Community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 1999; 10: 795-802.
46. Wistuba II, Behrens C, Gazdar AF. Pathogenesis of non-AIDS-defining cancers: A review. AIDS Patient Care STDS 1999; 13: 415-26.
47. Hales M, Bottles K, Miller T, Donegan E, Ljung BM. Diagnosis of Kaposi's sarcoma by fine-needle aspiration biopsy. Am J Clin Pathol 1987; 88: 20-5.
48. Katano H, Suda T, Morishita Y et al. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol 2000; 13: 77-85.
49. Cesarman E, Knowles DM. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol 1999; 9: 165-74.
50. Alkan S, Eltoum IA, Tabbara S, Day E, Karcher DS. Usefulness of molecular detection of human herpesvirus-8 in the diagnosis of Kaposi sarcoma by fine-needle aspiration. Am J Clin Pathol 1999; 111: 91-6.
51. Tulpule A, Levine A. AIDS-related lymphoma. Blood Rev 1999; 13: 147-50.
52. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999; 83: 481-5.
53. Carbone A, Gloghini A, Volpe R et al. [The pathology spectrum of AIDS-related non-Hodgkin's lymphoma]. Pathologica 1998; 90: 763-70.
54. Roth EL. Acquired immunodeficiency syndrome-related lymphoma. Semin Oncol Nurs 1998; 14: 284-92.
55. Straus DJ. Human immunodeficiency virus-associated lymphomas. Med Clin North Am 1997; 81: 495-510.
56. Straus DJ. HIV-associated lymphomas. Curr Opin Oncol 1997; 9: 450-4.
57. Gaidano G, Carbone A, Dalla-Favera R. Pathogenesis of AIDS-related lymphomas: Molecular and histogenetic heterogeneity. Am J Pathol 1998; 152: 623-30.
58. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification - From controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11 (Suppl. 1): 3-10.
59. Sakurada K. [AIDS-related malignancy]. Hokkaido Igaku Zasshi 1993; 68: 612-4.
60. Brown RS, Campbell C, Lishman SC, Spittle MF, Miller RF. Plasmablastic lymphoma: A new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma. Clin Oncol 1998; 10: 327-9.
61. Mansour G, Charlotte F, Calvez V, Davi F, Merle-Beral H. AIDS-related primary lymphoma of the pleural cavity. A case report. Acta Cytol 1998; 42: 371-3.
62. Vadmal MS, Smilari TF, Brody JP, Koduru P, Hajdu SI. Cytodiagnosis of a primary effusion lymphoma. A case report. Acta Cytol 1998; 42: 374-6.
63. Said JW, Shintaku IP, Asou H et al. Herpes-virus 8 inclusions in primary effusion lymphoma: Report of a unique case with T-cell phenotype. Arch Pathol Lab Med 1999; 123: 257-60.
64. Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: A unique B-cell neoplasm. Hum Pathol 1997; 28: 801-8.
65. Beylot-Barry M, Vergier B, Masquelier B et al. The spectrum of cutaneous lymphomas in HIV infection: A study of 21 cases. Am J Surg Pathol 1999; 23: 1208-16.
66. Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994; 73: 2400-7.
67. Roithmann S, Tourani JM, Gastaut JA et al. [Hodgkin's disease associated with HIV infection: Clinical characteristics and development. French registry of tumors associated with HIV infection]. Bull Cancer 1992; 79: 873-82.
68. Serraino D, Carbone A, Franceschi S, Tirelli U. Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin's disease in HIV-infected patients. Italian Cooperative Group on AIDS and Tumours. Eur J Cancer 1993; 29A: 1948-50.
69. Ree HJ, Strauchen JA, Khan AA et al. Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistio-cytoid stromal cells [see comments]. Cancer 1991; 67: 1614-21.
70. Andrieu JM, Roithmann S, Tourani JM et al. Hodgkin's disease during HIV1 infection: The French registry experience. French Registry of HIV-Associated Tumors. Ann Oncol 1993; 4: 635-41.
71. Hocke C, Leroy V, Morlat P et al. Cervical dysplasia and human immunodeficiency virus infection in women: Prevalence and associated factors. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GESCA). Eur J Obstet Gynecol Reprod Biol 1998; 81: 69-76.
72. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst Monogr 1998; 23: 43-9.
73. Petry KU, Bohmer G, Iftner T, Flemming P, Stoll M, Schmidt RE. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women. 1990-98. Gynecol Oncol 1999; 75: 427-31.
74. Baughman RP, Dohn MN, Frame PT. The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994; 97: 515-22.
75. Breuer R, Lossos IS, Lafair JS, Engelhard D. Utility of bronchoalveolar lavage in the assessment of di3use pulmonary infiltrates in non-AIDS immunocompromised patients. Respir Med 1990; 84: 313-6.
76. Taylor IK, Coker RJ, Clarke J et al. Pulmonary complications of HIV disease: 10 Year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax 1995; 50: 1240-5.
77. Piller CF, Clark DP. Pathologic outcome in HIV-seropositive individuals with nonspecific bronchoalveolar lavage cytology. Acta Cytol 1998; 42: 913-7.
78. Miller RF, Howling SJ, Reid AJ, Shaw PJ. Pleural effusions in patients with AIDS. Sex Trans Infect 2000; 76: 122-5.
79. Jones D, Lieb T, Narita M, Hollender ES, Pitchenik AE, Ashkin D. Mesothelial cells in tuberculous pleural effusions of HIV-infected patients. Chest 2000; 117: 289-91.
80. Ellison E, Lapuerta P, Martin SE. Cytologic features of mycobacterial pleuritis: Logistic regression and statistical analysis of a blinded, case-controlled study. Diagn Cytopathol 1998; 19: 173-6.
81. Strigle SM, Rarick MU, Cosgrove MM, Martin SE. A review of the fine-needle aspiration cytology findings in human immunodeficiency virus infection. Diagn Cytopathol 1992; 8: 41-52.
82. Harkin TJ, Ciotoli C, Addrizzo-Harris DJ, Naidich DP, Jagirdar J, Rom WN. Transbronchial needle aspiration (TBNA) in patients infected with HIV. Am J Respir Crit Care Med 1998; 157: 1913-8.
83. Ellison E, Lapuerta P, Martin SE. Fine needle aspiration (FNA) in HIV+ patients: Results from a series of 655 aspirates. Cytopathol 1998; 9: 222-9.
84. Reid AJ, Miller RF, Kocjan GI. Diagnostic utility of fine needle aspiration (FNA) cytology in HIV-infected patients with lymphadenopathy [see comments]. Cytopathol 1998; 9: 230-9.
85. Grossl NA, Mosunjac MI, Wallace TM. Utility of fine needle aspiration in HIV-positive patients with corresponding CD4 counts. Four years' experience in a large inner city hospital. Acta Cytol 1997; 41: 811-6.
86. Strigle SM, Gal AA. Review of the central nervous system cytopathology in human immunodeficiency virus infection. Diagn Cytopathol 1991; 7: 387-401.
87. Manji H, Miller RF. Progressive multifocal leucoencephalopathy: Progress in the AIDS era [in process citation]. J Neurol Neurosurg Psychiatry 2000; 69: 569-71.
88. Cardo DM, Culver DH, Ciesielski CA et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337: 1485-90.
89. www.doh.gov.uk/chcguid1.htm.